New Hope for TB: FDA Approves New Treatment for Highly Drug-Resistant Forms of Tuberculosis
New Hope for TB: FDA Approves New Treatment for Highly Drug-Resistant Forms of Tuberculosis By: TB Alliance | Reprented with Premission NEW YORK (August 14, 2019)—Pretomanid, a novel compound developed by the non-profit organization TB Alliance, was approved by the U.S. Food & Drug Administration (FDA) today for treating some [..]
